The NHS will start offering the GLP-1 drug semaglutide (Wegovy) to eligible patients in England within months, as draft guidance from NICE recommends its use from this summer.
A recent clinical trial published in JACC found that baduanjin, a traditional mind‑body exercise related to qigong, lowered systolic blood pressure in people with hypertension.
On March 19 the FDA approved a higher-dose version of the weight-loss drug Wegovy. Branded as Wegovy HD, the new formulation delivers 7.2 mg of semaglutide by weekly injection, up from…
A large Swedish registry study suggests that GLP-1 receptor agonists — notably semaglutide (marketed as Ozempic and Wegovy) and liraglutide — are associated with a lower risk of…
Stopping GLP-1 medications such as semaglutide (Ozempic, Wegovy) can rapidly erase the cardiovascular gains achieved while using them.
On November 26, 2025, 62-year-old Tommy Bell, a patient transport supervisor at AdventHealth DeLand who had worked at the hospital for more than a decade, felt persistent pressure in…
A recent analysis found that excess belly fat predicts future heart failure better than overall body weight or BMI, and that systemic inflammation helps explain much of the…
The American College of Cardiology (ACC), the American Heart Association (AHA) and nine other medical organizations released updated dyslipidemia guidelines replacing the 2018 AHA/ACC…
A recent analysis suggests the high-dose semaglutide product Wegovy may be associated with an elevated reporting rate of ischemic optic neuropathy (ION), a rare but serious cause of…
GLP-1 medications such as Ozempic and Wegovy typically produce about 15–20% body-weight loss, and are often prescribed as long-term therapies because many people regain weight after…
Obesity now accounts for about 10% of all new cancer diagnoses in the United States each year, and for up to half of some cancers — notably endometrial and liver cancer — according to…
Art Alexakis, frontman of Everclear, has spent the past decade living with relapsing multiple sclerosis while continuing to tour and record.